Altimmune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.About ALT
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.
CEOVipin K. Garg
CEOVipin K. Garg
Employees59
Employees59
HeadquartersGaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded1997
Founded1997
Employees59
Employees59
ALT Key Statistics
Market cap548.84M
Market cap548.84M
Price-Earnings ratio-4.93
Price-Earnings ratio-4.93
Dividend yield—
Dividend yield—
Average volume3.86M
Average volume3.86M
High today$6.03
High today$6.03
Low today$5.25
Low today$5.25
Open price$5.40
Open price$5.40
Volume6.38M
Volume6.38M
52 Week high$9.59
52 Week high$9.59
52 Week low$2.90
52 Week low$2.90
Stock Snapshot
Altimmune(ALT) stock is priced at $5.25, giving the company a market capitalization of 548.84M. It carries a P/E multiple of -4.93.
On 2025-12-13, Altimmune(ALT) stock traded between a low of $5.25 and a high of $6.03. Shares are currently priced at $5.25, which is 0.0% above the low and -12.9% below the high.
The Altimmune(ALT)'s current trading volume is 6.38M, compared to an average daily volume of 3.86M.
In the last year, Altimmune(ALT) shares hit a 52-week high of $9.59 and a 52-week low of $2.90.
In the last year, Altimmune(ALT) shares hit a 52-week high of $9.59 and a 52-week low of $2.90.
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
12.5%
Sell
12.5%
People also own
Based on the portfolios of people who own ALT. This list is generated using Robinhood data, and it’s not a recommendation.